Fulgence K Kassi1, Virginie Bellet2, Pascal Drakulovski2, Donika Krasteva2, Frédéric Roger2, Bedia-Tanoh A Valérie1, Touré Aboubakar1, Adama Doumbia3, Gisèle A Kouakou3, Eric Delaporte4, Jacques Reynes4, William Yavo1, Hervé I E Menan1, Sebastien Bertout2. 1. Laboratoire de Parasitologie et de Mycologie - CeDReS (Centre de Diagnostic et de Recherche sur le SIDA et les Autres Maladies Infectieuses), UFR Pharmacie, CHU de Treichville, Université Félix Houphouët Boigny, Abidjan, Ivory Coast. 2. UMI 233 IRD-UM INSERM U1175 TransVIHMI, Groupe Infections Fongique et Parasitaire Laboratoire de Parasitologie et de Mycologie Médicale, UFR Pharmacie, Montpellier Cedex 5, France. 3. Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Ivory Coast. 4. UMI 233 Service des Maladies Infectieuses et Tropicales, CHU Gui de Chauliac, Montpellier, France.
Abstract
PURPOSE: The aim of this study was to assess the biotope of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast, and clarify the possible epidemiological relationship between environmental and clinical strains. METHODOLOGY: Samples from Eucalyptus camaldulensis (n=136), Mangifera indica (n=13) and pigeon droppings (n=518) were collected from different sites close to the living environment of Ivorian HIV patients with cryptococcosis (n=10, 50 clinical strains). Clinical and environmental strains were characterized by molecular serotyping and genotyping [RFLP analysis of the URA5 gene, (GACA)4, (GTG)5 and M13 PCR fingerprinting] and compared.Results/Key findings. Environmental strains were recovered only from the pigeon droppings. In vitro susceptibility profiles showed that all strains were susceptible to fluconazole, flucytosine and amphotericin B. All environmental strains consisted of C. neoformans (A, AFLP1/VNI), whereas clinical strains included C. neoformans (A, AFLP1/VNI), C. neoformans x Cryptococcus deneoformans hybrids (AD, AFLP3/VNIII) and Cryptococcus deuterogattii (B, AFLP6/VGII). Two patients were co-infected with both C. neoformans and C. neoformans x C. deneoformans hybrids. We noticed a low genetic diversity among the environmental samples compared to the high diversity of the clinical samples. Some clinical strains were genetically more similar to environmental strains than to other clinical strains, including those from the same patient. CONCLUSION: These results provide new information on the ecology and epidemiology of the C. neoformans/C. gattii species complex in Ivory Coast.
PURPOSE: The aim of this study was to assess the biotope of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast, and clarify the possible epidemiological relationship between environmental and clinical strains. METHODOLOGY: Samples from Eucalyptus camaldulensis (n=136), Mangifera indica (n=13) and pigeon droppings (n=518) were collected from different sites close to the living environment of Ivorian HIVpatients with cryptococcosis (n=10, 50 clinical strains). Clinical and environmental strains were characterized by molecular serotyping and genotyping [RFLP analysis of the URA5 gene, (GACA)4, (GTG)5 and M13 PCR fingerprinting] and compared.Results/Key findings. Environmental strains were recovered only from the pigeon droppings. In vitro susceptibility profiles showed that all strains were susceptible to fluconazole, flucytosine and amphotericin B. All environmental strains consisted of C. neoformans (A, AFLP1/VNI), whereas clinical strains included C. neoformans (A, AFLP1/VNI), C. neoformans x Cryptococcus deneoformans hybrids (AD, AFLP3/VNIII) and Cryptococcus deuterogattii (B, AFLP6/VGII). Two patients were co-infected with both C. neoformans and C. neoformans x C. deneoformans hybrids. We noticed a low genetic diversity among the environmental samples compared to the high diversity of the clinical samples. Some clinical strains were genetically more similar to environmental strains than to other clinical strains, including those from the same patient. CONCLUSION: These results provide new information on the ecology and epidemiology of the C. neoformans/C. gattii species complex in Ivory Coast.
Authors: Amaury Dos Santos Bentes; Bodo Wanke; Márcia Dos Santos Lazéra; Ana Karla Lima Freire; Roberto Moreira da Silva Júnior; Diego Fernando Silva Rocha; Silviane Bezerra Pinheiro; Steven Edward Zelski; Ani Beatriz Jackisch Matsuura; Liliane Coelho da Rocha; Erica Simplício de Souza; João Vicente Braga de Souza Journal: Braz J Microbiol Date: 2019-03-09 Impact factor: 2.476
Authors: Supavit Chesdachai; Radha Rajasingham; Melanie R Nicol; David B Meya; Felix Bongomin; Mahsa Abassi; Caleb Skipper; Richard Kwizera; Joshua Rhein; David R Boulware Journal: Open Forum Infect Dis Date: 2019-10-01 Impact factor: 3.835
Authors: Maphori Maliehe; Mathope A Ntoi; Shayanki Lahiri; Olufemi S Folorunso; Adepemi O Ogundeji; Carolina H Pohl; Olihile M Sebolai Journal: Microorganisms Date: 2020-01-28
Authors: Sally H Mohamed; Tinashe K Nyazika; Kenneth Ssebambulidde; Michail S Lionakis; David B Meya; Rebecca A Drummond Journal: Front Immunol Date: 2022-04-01 Impact factor: 8.786
Authors: Lana Sarita de Souza Oliveira; Luciana Magalhães Pinto; Mariana Araújo Paulo de Medeiros; Dena L Toffaletti; Jennifer L Tenor; Tânia Fraga Barros; Rejane Pereira Neves; Reginaldo Gonçalves de Lima Neto; Eveline Pipolo Milan; Ana Carolina Barbosa Padovan; Walicyranison Plinio da Silva Rocha; John R Perfect; Guilherme Maranhão Chaves Journal: Front Cell Infect Microbiol Date: 2021-07-01 Impact factor: 5.293